Antagonistic Activity of Nocardia brasiliensis PTCC 1422 Against Isolated Enterobacteriaceae from Urinary Tract Infections

Probiotics and Antimicrobial Proteins

Volumn 8, Issue 1, 2016, Pages 41-45

  Jalali, Hossnieh Kafshdar ^a   Salamatzadeh, Abdolreza ^a,b   Jalali, Arezou Kafshdar ^a   Kashani, Hamed Haddad ^c   Asbchin, Salman Ahmadi ^d   Issazadeh, Khosro ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b FARHANGIAN UNIVERSITY   (Iran)

^c KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF MAZANDARAN   (Iran)

Author keywords

Antagonistic activity; Enterobacteriaceae; Nocardia brasiliensis; Urinary tract infections

Indexed keywords

CEFALEXIN; CEFALOTIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; NALIDIXIC ACID; PENICILLIN DERIVATIVE; PHTHALIC ACID; TETRACYCLINE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; DISK DIFFUSION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; INHIBITION ZONE; KLEBSIELLA PNEUMONIAE; MASS FRAGMENTOGRAPHY; NOCARDIA BRASILIENSIS; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; SERRATIA MARCESCENS; URINARY TRACT INFECTION; CHEMISTRY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NOCARDIA; PHYSIOLOGY; PRECLINICAL STUDY;

ANTI-BACTERIAL AGENTS; DRUG EVALUATION, PRECLINICAL; ENTEROBACTERIACEAE; HUMANS; MICROBIAL SENSITIVITY TESTS; NOCARDIA; URINARY TRACT INFECTIONS;

EID: 84964262443     PISSN: 18671306     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12602-016-9207-0     Document Type: Article

References (20)

1. Annadurai G (2000) Design of optimum response surface experiments for adsorption of direct dye on chitosan. Bioprocess Eng 23(5):451–455
2. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R (2004) Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 23(3):163–167
3. El-Helow E, Sabry S, Amer R (2000) Cadmium biosorption by a cadmium resistant strain of Bacillus thuringiensis: regulation and optimization of cell surface affinity for metal cations. Biometals 13(4):273–280
4. Karatzas KA, Webber MA, Jorgensen F, Woodward MJ, Piddock LJ, Humphrey TJ (2007) Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. J Antimicrob Chemother 60(5):947–955
5. Khucharoenphaisan K, Sripairoj N, Sinma K (2012) Isolation and identification of actinomycetes from termite’s gut against human pathogen. Asian J Anim Vet Adv 7:68–73
6. Komatsu K, Tsuda M, Shiro M, Tanaka Y, Mikami Y, Kobayashi JI (2004) Brasilicardins B–D, new tricyclic terpernoids from actinomycete Nocardia brasiliensis. Bioorg Med Chem 12(21):5545–5551
7. Ligor M, Buszewski B (2006) An investigation of the formation of taste and odour contaminants in surface water using the headspace SPME-GC/MS method. Pol J Environ Stud 15(3):429–435
8. Maharjan S, Koju D, Lee HC, Yoo JC, Sohng JK (2012) Metabolic engineering of Nocardia sp. CS682 for enhanced production of nargenicin A1. Appl Biochem Biotechnol 166(3):805–817
9. Mikami Y, Yazawa K, Nemoto A, Komaki H, Tanaka Y, Graefe U (1999) Production of erythromycin E by pathogenic Nocardia brasiliensis. J Antibiot 52(2):201–202
10. Mitra A, Santra SC, Mukherjee J (2008) Distribution of actinomycetes, their antagonistic behaviour and the physico-chemical characteristics of the world’s largest tidal mangrove forest. Appl Microbiol Biotechnol 80(4):685–695
11. Mukai A, Fukai T, Matsumoto Y, Ishikawa J, Hoshino Y, Yazawa K, Mikami Y (2006) Transvalencin Z, a new antimicrobial compound with salicylic acid residue from Nocardia transvalensis IFM 10065. J Antibiot 59(6):366–369
12. Noor N, Ajaz M, Rasool SA, Pirzada ZA (2004) Urinary tract infections associated with multidrug resistant enteric bacilli: characterization and genetical studies. Pak J Pharm Sci 17(2):115–123
13. Pitout JD (2010) Infections with extended-spectrum β-lactamase-producing Enterobacteriaceae. Drugs 70(3):313–333
14. Pitout JD, Nordmann P, Laupland KB, Poirel L (2005) Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 56(1):52–59
15. Rakshanya U, Shenpagam H, Devi DK (2011) Antagonistic activity of actinomycetes isolates against human pathogen. J. Microbiol Biotech Res 1(2):74–79
16. Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP et al (2008) Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Arch Intern Med 168(17):1897–1902
17. Singh N, Rai V (2013) In vitro antimycotic activity of a new isolate Streptomyces fradiae MTCC 11051 against the multi-drug resistant pathogenic fungi. J Pharm Res 7(4):331–336
18. Srifuengfung S, Poonwan N, Tribuddharat C, Chokephaibulkit K (2007) Prevalence of nocardia species isolated from patients with respiratory tract infections at Siriraj Hospital, Thailand. J Infect Dis Antimicrob Agents 24:1–6
19. Verma VC, Gond SK, Kumar A, Mishra A, Kharwar RN, Gange AC (2009) Endophytic actinomycetes from Azadirachta indica A. Juss.: isolation, diversity, and anti-microbial activity. Microb Ecol 57(4):749–756
20. Vimal V, Rajan BM, Kannabiran K (2009) Antimicrobial activity of marine actinomycete, Nocardiopsis sp. VITSVK 5 (FJ973467). Asian J Med Sci 1(2):57–63